Skip to content

DERMANOB

Active
Private limited companyfounded 20215 yrs activeTervurenlaan 312, 1150 Sint-Pieters-Woluwe, BelgiumKBO/BCE: BE 0768.622.555
Summary

The computed 12-month bankruptcy probability of DERMANOB is 4.2% (elevated). The 2025 annual accounts show equity of €4,369 and a net result of €84,369. Equity is growing by ~44.7% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability100=
Solvency27▼-73
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
4.2% Elevated
0%0.5%1.5%4%10%≥ 25%
No publishable credit limit; credit only on tighter terms
Liquidity tight (current ratio 1.01 against 41.67 in 2024; short-term debt: 98.4% and cash: 96.1% of total assets), and 98.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 5 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
1.6%
Return on assets
31.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-02-2026, 177 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
177 d early
2024
43 d early
2023
51 d early
2022
28 d late
2021
51 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 5 accounts on average 59 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 11 June (4 of the last 5 filed years within 78 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 21 May 2021, DERMANOB was incorporated as a Private limited company.1 Total assets went from EUR 67,709 in 2021 to EUR 270,648 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2021 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€4,369▼ 97.8%
2024 · €197,728
Total assets
€270,648▲ 33.6%
2024 · €202,512
Net result
€84,369▲ 34.8%
2024 · €62,574
Working capital
€1,897▼ 99.0%
2024 · €194,543
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€59,395-€60,633▲ 2.1%€72,183▲ 19.0%€78,606▲ 8.9%€113,702▲ 44.6%
Net result€47,380-€48,138▲ 1.6%€57,401▲ 19.2%€62,574▲ 9.0%€84,369▲ 34.8%
Equity€51,380-€99,518▲ 93.7%€156,919▲ 57.7%€197,728▲ 26.0%€4,369▼ 97.8%
Total assets€67,709-€121,135▲ 78.9%€173,299▲ 43.1%€202,512▲ 16.9%€270,648▲ 33.6%
Debt€16,329-€21,617▲ 32.4%€16,380▼ 24.2%€4,783▼ 70.8%€266,279▲ 5,467%
Working capital€53,891-€101,293▲ 88.0%€156,919▲ 54.9%€194,543▲ 24.0%€1,897▼ 99.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000Operating result 2021: €59,395€59,395Net result 2021: €47,380€47,380Operating result 2022: €60,633€60,633Net result 2022: €48,138€48,138Operating result 2023: €72,183€72,183Net result 2023: €57,401€57,401Operating result 2024: €78,606€78,606Net result 2024: €62,574€62,574Operating result 2025: €113,702€113,702Net result 2025: €84,369€84,36920212022202320242025€0€50,000€100,000Operating result 2023: €72,183€72,200Net result 2023: €57,401€57,400Operating result 2024: €78,606€78,600Net result 2024: €62,574€62,600Operating result 2025: €113,702€114,000Net result 2025: €84,369€84,400202320242025
The operating result has risen four years in a row; 2025 is 45% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €270,648
Fixed assets €2,471 ▼ 22.4%
Current assets €268,176 ▲ 34.5%
Equity and liabilities €270,648
Equity €4,369 ▼ 97.8%
Debt €266,279 ▲ 5,467%
Debt's share of the balance-sheet total rises from 2.4% to 98.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€114,415▲
2024 · €78,990
Cash flow
€85,083▲
2024 · €62,958
Current ratio
1.01▼
2024 · 41.67
Debt to equity
60.95▲
2024 · 0.02
ROA
31.2%▲
2024 · 30.9%
Interest coverage
1525.54▲
2024 · 1074.70
Debt ≤ 1 year
€266,279▲
2024 · €4,783
Income taxes
€29,258▲
2024 · €15,958
A ratio outside any meaningful range has been withheld (balance sheet total €270,648, equity €4,369).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,153 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
1.7% went bankrupt
2.2% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 4.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,153 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet Code20242025
Assets
Total assets20/58€202,512€270,648▲
Fixed assets21/28€3,185€2,471▼
Tangible fixed assets22/27€3,185€2,471▼
Other tangible fixed assets26€3,185€2,471▼
Current assets29/58€199,327€268,176▲
Amounts receivable within one year40/41€8,042€8,042=
Other amounts receivable41€8,042€8,042=
Cash at bank and in hand54/58€191,285€260,135▲
Equity and liabilities
Total equity and liabilities10/49€202,512€270,648▲
Equity10/15€197,728€4,369▼
Contributions10/11€4,000€4,000=
Reserves13€193,728€369▼
Distributable reserves133€193,728€369▼
Amounts payable17/49€4,783€266,279▲
Amounts payable within one year42/48€4,783€266,279▲
Trade debts44€1,048€1,869▲
Suppliers440/4€1,048€1,869▲
Taxes, remuneration and social security45€3,265€48,917▲
Taxes450/3€3,265€48,917▲
Other amounts payable47/48€471€215,493▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€384€714▲
Other operating charges640/8€618€884▲
Gross operating margin9900€79,609€115,299▲
Operating profit (loss)9901€78,606€113,702▲
Financial charges65/66B€74€75▲
Recurring financial charges65€74€75▲
Profit (loss) for the period before taxes9903€78,533€113,627▲
Income taxes67/77€15,958€29,258▲
Profit (loss) for the period9904€62,574€84,369▲
Profit (loss) for the period to be appropriated9905€62,574€84,369▲
Appropriation of the result
Profit (loss) to be appropriated9906€62,574€84,369▲
Transfer from equity791/2-€193,728
Transfer to equity691/2€40,809€369▼
To the legal reserve6920€40,809-
To other reserves6921-€369
Profit to be distributed694/7€21,765€277,728▲
Return on contributions (dividend)694€21,765€277,728▲

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630---€384€714▲ 85.8%
Other operating charges640/8€201€1,440€219€618€884▲ 42.9%
Gross operating margin9900€59,597€62,073€72,403€79,609€115,299▲ 44.8%
Operating profit (loss)9901€59,395€60,633€72,183€78,606€113,702▲ 44.6%
Financial charges65/66B€37€69€69€74€75▲ 2.0%
Recurring financial charges65€37€69€69€74€75▲ 2.0%
Profit (loss) for the period before taxes9903€59,358€60,564€72,114€78,533€113,627▲ 44.7%
Income taxes67/77€11,978€12,426€14,713€15,958€29,258▲ 83.3%
Profit (loss) for the period9904€47,380€48,138€57,401€62,574€84,369▲ 34.8%
Profit (loss) for the period to be appropriated9905€47,380€48,138€57,401€62,574€84,369▲ 34.8%
Line20212022202320242025Change
Assets
Total assets20/58€67,709€121,135€173,299€202,512€270,648▲ 33.6%
Fixed assets21/28---€3,185€2,471▼ 22.4%
Tangible fixed assets22/27---€3,185€2,471▼ 22.4%
Other tangible fixed assets26---€3,185€2,471▼ 22.4%
Current assets29/58€67,709€121,135€173,299€199,327€268,176▲ 34.5%
Amounts receivable within one year40/41---€8,042€8,042=
Other amounts receivable41---€8,042€8,042=
Cash at bank and in hand54/58€64,654€121,135€173,299€191,285€260,135▲ 36.0%
Deferred charges and accrued income490/1€3,055-----
Equity and liabilities
Total equity and liabilities10/49€67,709€121,135€173,299€202,512€270,648▲ 33.6%
Equity10/15€51,380€99,518€156,919€197,728€4,369▼ 97.8%
Contributions10/11€4,000€4,000€4,000€4,000€4,000=
Reserves13€47,380€95,518€152,919€193,728€369▼ 99.8%
Distributable reserves133€47,380€95,518€152,919€193,728€369▼ 99.8%
Amounts payable17/49€16,329€21,617€16,380€4,783€266,279▲ 5,467%
Amounts payable within one year42/48€13,818€19,842€16,380€4,783€266,279▲ 5,467%
Trade debts44€368€5,912€354€1,048€1,869▲ 78.4%
Suppliers440/4€368€5,912€354€1,048€1,869▲ 78.4%
Taxes, remuneration and social security45€11,978€12,426€14,713€3,265€48,917▲ 1,398%
Taxes450/3€11,978€12,426€14,713€3,265€48,917▲ 1,398%
Other amounts payable47/48€1,472€1,504€1,312€471€215,493▲ 45,639%
Accrued charges and deferred income492/3€2,511€1,775----
Line20212022202320242025Change
Profit (loss) for the period9904€47,380€48,138€57,401€62,574€84,369▲ 34.8%
+ Depreciation and write-downs630---€384€714▲ 85.8%
Operating cash flow (approximation)€47,380€48,138€57,401€62,958€85,083▲ 35.1%
Investment in fixed assets (approximation)----€0-
Change in cash-€56,480€52,164€17,986€68,850▲ 283%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
04-02
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2021net €84,369 ▲34.8%
Operating result €113,702, net result €84,369, both a record.
18-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Liquidity quadruplescurrent ratio 41.67
Current ratio from 10.58 to 41.67; short-term debt falls from €16,380 to €4,783.
10-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Equity above €150,000Eq €156,919 ▲57.7%
3 profitable years in a row build equity to €156,919.
28-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
10-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Pieters-Woluwe · 1 establishment unit since 2021
seat establishment The establishment unit on the map
Ground area
305 m²
Building footprint
267 m²
Volume, LiDAR
3,237 m³
Parcel 21684B0012/00F002, Brussels · tallest building 28.8 m, ±1 floor. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
DERMANOB
Tervurenlaan 312, 1150 Sint-Pieters-WoluweSpecialist medical practice
since 20212.318.567.541
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21684B0012/00F002 Brussels 305 m² 1 · 267 m² 28.8 m · 1 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded21-05-2021
Fiscal year end31-12
Contact
E-mail dermanob21@gmail.com
E-invoicing
Reachable via Peppol
Peppol ID 0208:0768622555
Registered 25-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.